Xenetic Biosciences
XBIO
13 hedge funds and large institutions have $293K invested in Xenetic Biosciences in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 1 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
1.17% more ownership
Funds ownership: 5.81% → 6.98% (+1.2%)
0% more funds holding
Funds holding: 13 → 13 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
18% less capital invested
Capital invested by funds: $356K → $293K (-$63K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$37.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$15.3K |
| 3 |
S
Sachetta
Lynnfield,
Massachusetts
|
+$12.9K |
| 4 |
Renaissance Technologies
New York
|
+$4.75K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$3.66K |
| 2 |
AIP
Alexis Investment Partners
Montgomery,
Texas
|
-$100 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $69.9K | +$4.75K | +1,214 | +5% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $66.3K | +$37.3K | +9,529 | +60% |
|
|
3
Citadel Advisors
Miami,
Florida
| $45.1K | +$15.3K | +3,909 | +29% |
|
|
LGF
4
LGT Group Foundation
Vaduz,
Liechtenstein
| $41.1K | – | – | – |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $28.6K | -$3.66K | -936 | -8% |
|
|
S
6
Sachetta
Lynnfield,
Massachusetts
| $27.8K | +$12.9K | +3,295 | +45% |
|
|
JEST
7
JTC Employer Solutions Trustee
St Helier,
Jersey
| $7K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $6.61K | +$3.42K | +875 | +53% |
|
9
Barclays
London,
United Kingdom
| $585 | +$876 | +224 | New |
|
10
Bank of America
Charlotte,
North Carolina
| $29 | – | – | – |
|
|
SS
11
SBI Securities
Tokyo,
Japan
| $13 | – | – | – |
|
12
Morgan Stanley
New York
| $11 | +$12 | +3 | +300% |
|
|
DWM
13
Darwin Wealth Management
Tampa,
Florida
| $7 | – | – | – |
|
|
AIP
14
Alexis Investment Partners
Montgomery,
Texas
| – | -$100 | -25 | Closed |
|
XBIO Hedge Fund Activity: Q1 2025 in Review
13 of the 7,464 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences (XBIO) for Q1 2025, worth a combined $293K — down 18% from $356K a quarter earlier.
Fund positioning in XBIO was balanced in Q1 2025: 1 fund opened new positions, 1 closed out, 6 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $37.3K. The largest seller was Geode Capital Management, cutting an estimated $3.66K.
- 13 institutional investors held Xenetic Biosciences (XBIO) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $293K of Xenetic Biosciences stock for Q1 2025, down 18% quarter-over-quarter.
- 1 fund opened new Xenetic Biosciences positions in Q1 2025 and 1 closed out, a net change of 0 holders.
- The largest Xenetic Biosciences buyer in Q1 2025 was Susquehanna International Group, an estimated $37.3K added.
- The largest Xenetic Biosciences seller in Q1 2025 was Geode Capital Management, an estimated $3.66K sold.
Based on aggregated 13F filings for Q1 2025.